REFRACTORY PLASMA CELL MYELOMA
Clinical trials for REFRACTORY PLASMA CELL MYELOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY PLASMA CELL MYELOMA trials appear
Sign up with your email to follow new studies for REFRACTORY PLASMA CELL MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can nivolumab rescue patients when CAR T-Cell therapy fails?
Disease control CompletedThis phase 2 trial tested nivolumab, an immunotherapy drug, in 20 people with blood cancers like lymphoma, leukemia, or myeloma that came back or didn't respond after CAR T-cell therapy. The goal was to see if nivolumab could help the immune system attack the cancer again. The st…
Matched conditions: REFRACTORY PLASMA CELL MYELOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New drug combo shows promise for returning bone marrow cancer
Disease control CompletedThis study tested a drug called ixazomib, alone or with other medicines, in 165 people whose multiple myeloma (a blood cancer) had come back. The goal was to see if these combinations could shrink or control the cancer. Participants received different treatment plans, and doctors…
Matched conditions: REFRACTORY PLASMA CELL MYELOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a common pain reliever boost a cancer drug? early trial underway
Disease control CompletedThis early-phase trial tested a combination of two drugs—selinexor and choline salicylate (a type of aspirin)—in 22 adults with certain lymphomas or multiple myeloma that had come back or not responded to treatment. The main goal was to find the safest dose and check for side eff…
Matched conditions: REFRACTORY PLASMA CELL MYELOMA
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC